Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds UPDATE: Clovis Oncology Says FDA Maintains Their Recommendation That Co. Wait For More Mature Overall Survival Data To Submit SNDA

UPDATE: Clovis Oncology Says FDA Maintains Their Recommendation That Co. Wait For More Mature Overall Survival Data To Submit SNDA

-Reuters

July 6, 2022

1 minute read

-Reuters

Cramer Is Holding This Biotech Stock

January 12, 10:16 AM

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended holding Biomarin Pharmaceutical Inc (NASDAQ: BMRN).

May 9, 9:13 AM

Bitcoin non-fungible tokens (NFTs) are gaining traction in the Web3 space as an increasing number of marketplaces embrace digital assets.

July 21, 8:46 AM

-Bloomberg

January 10, 9:53 AM

Morgan Stanley analyst Jeffrey Hung maintains CinCor Pharma (NASDAQ:CINC) with a Equal-Weight and raises the price target from $22 to $30.